QIR Suite vs CVI42

Direct competitors — feature-level head-to-head below. Comparability 90/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

QIR Suite

by CASIS Cardiac Simulation & Imaging Software

CVI42

by CIRCLE CARDIOVASCULAR IMAGING

AI Verdict

Both QIR Suite and CVI42 are direct competitors, offering AI-powered analysis of cardiac MR and CT images to support diagnosis and prognosis. While QIR Suite emphasizes broad quantitative evaluation of over 100 clinical parameters and pathological volumes, CVI42 provides a more detailed focus on coronary plaque analysis, vascular CT analysis, and advanced CMR automation. The choice between them may depend on the specific need for comprehensive coronary and vascular detail versus a wider range of general quantitative cardiac parameters.

Choose QIR Suite if…

Choose QIR Suite if your primary need is highly detailed, quantitative evaluation of a broad spectrum of cardiovascular parameters from MR and CT images. This tool excels in precise quantification of over 100 clinical parameters, including blood flow, pathological volumes, and myocardial perfusion, making it ideal for in-depth diagnostic and prognostic assessment of specific cardiac conditions.

View QIR Suite →

Choose CVI42 if…

Choose CVI42 if you require a comprehensive platform for both cardiac and vascular imaging analysis, particularly for detailed coronary assessment and procedural planning. Its strengths lie in AI-automated coronary lumen and wall segmentation, comprehensive plaque analysis (calcified, non-calcified, low-attenuation), and advanced vascular CT analysis tools, making it suitable for a holistic view of cardiovascular health and intervention planning.

View CVI42 →

For a physician evaluating AI tools for cardiovascular imaging, QIR Suite and CVI42 both offer advanced analysis capabilities for MR and CT images, yet they cater to slightly different needs. QIR Suite, from CASIS, emphasizes quantitative evaluation, providing over 100 clinical parameters, automatic segmentation, and specific quantification of blood flow, pathological volumes, and myocardial perfusion. It is deployed locally on dedicated hardware and is designed for in-depth, parameter-driven analysis of cardiac conditions.

CVI42, by Circle Cardiovascular Imaging, presents itself as a more comprehensive platform for both cardiac and vascular imaging. Its strengths lie in AI-automated coronary lumen and wall segmentation, detailed coronary plaque analysis, and advanced CMR automation including T1 mapping and 4D flow pre-processing. CVI42 also includes vascular CT analysis and planning tools, along with 3D visualization and image fusion. It is an on-premise solution with a flexible subscription model that scales across CT and MR service lines.

The key practical difference lies in their scope and focus. QIR Suite is best suited for physicians prioritizing extensive quantitative metrics and detailed analysis of specific cardiac functions. Physicians requiring a broader platform that encompasses both cardiac and vascular imaging, with a strong emphasis on coronary plaque analysis and advanced CMR automation, would likely find CVI42 more aligned with their needs. The choice between them depends on whether the physician’s primary requirement is deep, quantitative cardiac analysis or a wider, integrated platform for both cardiac and vascular imaging with advanced automation features.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	QIR Suite	CVI42
Pricing	Contact for pricing	Contact for pricing
Deployment	Locally on dedicated hardware	On-premise solution
FDA Status	1 AI-estimated	1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

CVI42

CVI42 is frequently praised in testimonials for its intuitive interface, optimized workflows, and core simplicity, enabling productive use in high-volume clinical settings. While QIR Suite also emphasizes optimized ergonomics and time-saving features through deep learning, the breadth of positive user feedback for CVI42 regarding its user experience is more prominent.

Clinical Value

CVI42

CVI42 offers a comprehensive platform for cardiac and vascular imaging, including advanced coronary plaque analysis with new reimbursement codes, interventional planning, and electrophysiology tools, enhancing diagnosis and patient care. QIR Suite provides extensive quantitative parameters and claims a 'world first solution to automatically evaluate a myocardial infarction,' but CVI42's broader scope, detailed plaque analysis, and strong market adoption with reimbursement support give it a slight edge.

Pricing & Value

CVI42

CVI42 clearly articulates a value proposition through its flexible, scalable 'Elevate' subscription model, which allows institutions to convert new reimbursement opportunities for AI-enabled plaque analysis into sustainable margins. QIR Suite offers both one-time license and subscription options, but lacks specific details on how its pricing directly translates into tangible financial value or reimbursement benefits for healthcare providers.

Enterprise Readiness

CVI42

Both tools have FDA clearance and offer on-premise deployment, which are crucial for healthcare enterprises. CVI42 explicitly details its DICOM and HL7 compatibility, flexible deployment options (standalone or client/server on Mac & Windows), and the ability to keep Protected Health Information (PHI) on the server, thereby reducing privacy risks. QIR Suite also supports PACS and HL7, and is ISO 13485 certified, but CVI42's detailed infrastructure and data handling assurances provide a more robust picture of enterprise readiness.

Innovation

CVI42

CVI42 demonstrates a strong commitment to continuous innovation with its 'next generation of products' and recent updates, including advanced CMR automation, comprehensive plaque analysis, and research-use PCAT tools. Its integration of external AI technology for vascular analysis also highlights a forward-thinking approach. While QIR Suite offers unique tools like aortic compliance and extracellular volume, CVI42's broader, more frequently updated, and specialized feature set suggests a more dynamic innovation pipeline.

Support & Docs

CVI42

CVI42 provides extensive evidence of strong customer support, including industry-leading Net Promoter Scores and Customer Satisfaction scores, global multi-language support, and comprehensive online documentation. QIR Suite does not provide comparable information regarding its customer support channels, documentation availability, or user satisfaction metrics, making it impossible to assess its offerings in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	QIR Suite	CVI42
Company	CASIS Cardiac Simulation & Imaging Software	CIRCLE CARDIOVASCULAR IMAGING
Primary Imaging Modalities	MR and CT images	CT and MRI
Coronary Plaque Analysis	Not specified	Comprehensive coronary plaque analysis (calcified, non-calcified, low-attenuation)
Blood Flow/Velocities Quantification	Blood flow/velocities quantification	Advanced CMR automation (4D flow pre-processing)
Strain Quantification	Strain quantification	specific modules like Strain require additional licenses.